微电生理-U
(688351)
| 流通市值：30.65亿 | | | 总市值：116.94亿 |
| 流通股本：1.23亿 | | | 总股本：4.71亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 89,152,510.16 | 329,194,871.27 | 236,071,421.62 | 142,122,680.52 |
| 营业收入 | 89,152,510.16 | 329,194,871.27 | 236,071,421.62 | 142,122,680.52 |
| 二、营业总成本 | 89,554,495.9 | 357,813,965.77 | 246,799,133.23 | 149,318,072.66 |
| 营业成本 | 35,175,840.03 | 120,117,175.69 | 81,325,416.26 | 45,991,884.34 |
| 税金及附加 | 902,989.67 | 2,202,487.66 | 1,741,697.41 | 996,120.49 |
| 销售费用 | 24,506,302.29 | 109,302,509.57 | 78,225,844.43 | 49,716,902.74 |
| 管理费用 | 10,252,315.73 | 40,846,150.5 | 25,975,402.15 | 15,543,971.49 |
| 研发费用 | 19,762,555.02 | 91,311,281.7 | 64,194,405.61 | 40,601,058.38 |
| 财务费用 | -1,045,506.84 | -5,965,639.35 | -4,663,632.63 | -3,531,864.79 |
| 其中:利息费用 | 262,016.52 | 1,269,968.04 | 1,028,700.46 | 681,578.43 |
| 其中:利息收入 | 1,522,998.4 | 6,833,739.41 | 5,031,810.73 | 3,315,689.21 |
| 加:公允价值变动收益 | 3,671,333.92 | 12,187,517.64 | 7,811,341.34 | 4,781,548.44 |
| 加:投资收益 | 1,892,646.06 | 10,136,954.91 | 9,222,012.67 | 5,938,168.53 |
| 资产减值损失(新) | -220,375.82 | -538,146.75 | -1,368,200.7 | -872,863.46 |
| 信用减值损失(新) | -231,059.64 | -1,353,444.96 | -1,327,448.49 | -1,028,789.01 |
| 其他收益 | 1,471,362.79 | 15,832,308.07 | 9,909,622 | 2,532,747.92 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0.01 |
| 四、营业利润 | 6,181,921.57 | 7,646,094.41 | 13,519,615.21 | 4,155,420.29 |
| 加:营业外收入 | - | 633.21 | 1.01 | 0.6 |
| 减:营业外支出 | 2,012,735.82 | 2,036,370.24 | 2,000,000 | 2,000,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,169,185.75 | 5,610,357.38 | 11,519,616.22 | 2,155,420.89 |
| 减:所得税费用 | - | -78,155.5 | - | - |
| 六、净利润 | 4,169,185.75 | 5,688,512.88 | 11,519,616.22 | 2,155,420.89 |
| 持续经营净利润 | 4,169,185.75 | 5,688,512.88 | 11,519,616.22 | 2,155,420.89 |
| 归属于母公司股东的净利润 | 4,169,185.75 | 5,688,512.88 | 11,519,616.22 | 2,155,420.89 |
| (一)基本每股收益 | 0.01 | 0.01 | 0.02 | 0 |
| (二)稀释每股收益 | 0.01 | 0.01 | 0.02 | 0 |
| 九、综合收益总额 | 4,169,185.75 | 5,688,512.88 | 11,519,616.22 | 2,155,420.89 |
| 归属于母公司股东的综合收益总额 | 4,169,185.75 | 5,688,512.88 | 11,519,616.22 | 2,155,420.89 |
| 公告日期 | 2024-04-26 | 2024-03-30 | 2023-10-27 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |